Common Stock, $0.001 par value
- Symbol
- SNES
- Exchange
- NASDAQ
- Classification
- COMMON
- Status
- Current
Current Report · Items 2.02, 9.01 · 8-K
SenesTech, Inc.
SNESNASDAQEQUITYCurrent
Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition. On October 15, 2026, SenesTech, Inc. (the "Company") issued a press release announcing preliminary revenue for the three months ended September 30, 2026. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference.…
Company context
SenesTech is committed to creating healthier environments by managing animal pest populations through birth control. The company’s groundbreaking products, including Evolve rodent birth control, integrate seamlessly into pest management programs, significantly enhancing their effectiveness while reducing reliance on traditional poisons. SenesTech’s mission is to create cleaner cities, more efficient businesses, and healthier communities with products that are effective and sustainable.
Current securities
Historical securities (1)
Recent company filings
- 4 filingOct 30, 2026
- SCHEDULE 13D/A - filed by GLENBROOK CAPITAL MANAGEMENT regarding SenesTech, Inc.Oct 30, 2026
- 4 filingOct 22, 2026
- SCHEDULE 13D/A - filed by GLENBROOK CAPITAL MANAGEMENT regarding SenesTech, Inc.Oct 22, 2026
- Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing · Regulation FD DisclosureOct 22, 2026
Registered securities in this filing
SenesTech, Inc. · 8-K · Filed 2026-10-15
Disclosure sections
Item 2.02Item 2.02 - Results of Operations
Item 2.02.
Results of Operations and Financial Condition.
On October 15, 2026, SenesTech, Inc. (the "Company") issued a press release announcing preliminary revenue for the three months ended September 30, 2026. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference.
The preliminary revenue information included in the press release is unaudited and subject to the completion of the Company’s normal quarter-end financial reporting procedures. The Company’s actual results may differ from the preliminary information, and the Company expects to report its complete financial results for the third quarter of 2026 in its Quarterly Report on Form 10-Q.
The information contained in this Item 2.02, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, except as may be expressly set forth by specific reference in such a filing.